Position statement on radiopharmaceutical production for clinical trials.

Bormans, G; Buck, A; Chiti, A; Cooper, M; Croasdale, J; Desruet, M; Kumar, V; Liu, Y; Penuelas, I; Rossetti, C; Schiavo, R; Schwarz, S W; Windhorst, A D

Bormans, G; Buck, A; Chiti, A; Cooper, M; Croasdale, J; Desruet, M; Kumar, V; Liu, Y; Penuelas, I; Rossetti, C; Schiavo, R; Schwarz, S W; Windhorst, A D.

Afiliación

Bormans G; 1Radiopharmaceutical Research KU Leuven, Leuven, Belgium.
Buck A; 2University of Wurzburg, Würzburg, Germany.
Chiti A; Humanitas University and Humanitas Research Hospital, Milan, Italy.
Cooper M; 4Royal Liverpool University Hospital, Liverpool, UK.
Croasdale J; 5Sandwell & West Birmingham Hospitals NHS Trust, Birmingham, UK.
Desruet M; Hospital Grenoble-Alpes, La Tronche, France.
Kumar V; 7Sydney Medical School, Sydney University, Camperdown, Australia.
Liu Y; 8European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Penuelas I; ClínicaUniversidad de Navarra, Pamplona, Spain.
Rossetti C; 10Ospedale Niguarda, Milan, Italy.
Schiavo R; 11Ospedale Belcolle, Viterbo, Italy.
Schwarz SW; 12Washington University School of Medicine, St. Louis, MO USA.
Windhorst AD; 13VU University Medical Center, Amsterdam, The Netherlands.

EJNMMI Radiopharm Chem ; 2(1): 12, 2017.

Article en En | MEDLINE | ID: mdl-29503853

Palabras clave

Clinical trials; Radiopharmaceuticals; Regulatory

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: EJNMMI Radiopharm Chem Año: 2017 Tipo del documento: Article País de afiliación: Bélgica